• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Frontline

Frontline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and Bromodomain Protein Inhibitors in Nonclinical Models of Acute Myeloid Leukemia

    Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and Bromodomain Protein Inhibitors in Nonclinical Models of Acute Myeloid Leukemia

  2. Glu Mobile Announces New Employment Inducement Awards

    Glu Mobile Announces New Employment Inducement Awards

  3. VisualDx Mobile App Hits 100 Million Image Views Milestone

    VisualDx Mobile App Hits 100 Million Image Views Milestone

  4. UPDATE: Russia nervously eyes the U.S.-Iran deal

    UPDATE: Russia nervously eyes the U.S.-Iran deal

  5. Professional Development Academy Closes IT Leadership Gap

    Professional Development Academy Closes IT Leadership Gap

  6. A Costly Education

    Amid soaring prices, financial planners need a role in solving what ails U.S. universities.

  7. Euronav NV Announces Final Results 2014 and New Dividend Policy

    Euronav NV Announces Final Results 2014 and New Dividend Policy

  8. To the Back of the Line, Frontline

    Rekenthaler drop-kicks PBS' documentary.

  9. Observations on 'The Retirement Gamble'

    Prudent Investor Advisors' Scott Simon offers thoughts on the recent PBS' Frontline broadcast.

  10. Bad Bet: 10-Year Treasuries

    After reviewing Avon's AVP most recent annual report, as well as recent investor presentations, we are raising our fair value estimate for the firm's shares. Avon's turnaround is finally gaining traction, and while it has taken slightly longer than we expected to reach this point, we now see more ...

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.